ACTIVE

NB PHARMA

Financial year 2025 · closed on 31/12/2025
Net result
56,7 k €
+19.3% YoY
Gross margin
272,3 k €
-8.2% YoY
Equity
574 k €
+11.0% YoY
Workforce
1,8 ETP
-30.8% YoY

What does NB PHARMA do?

NB PHARMA is a Private limited company incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Nieuwpoort. It employs on average 1,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0465.917.724
Incorporation
20/04/1999
Legal form
Private limited company
Registered office
Albert I laan 255
8620 Nieuwpoort · FlandreSee on map
Contributed capital
431 958,58 €
Latest accounts
31/12/2025
Average workforce
1,8 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 7 financial years

2025202420232022202120082007
Income statement
Gross margin272,3 k €296,7 k €255,6 k €-82,4 €-266,7 €58,4 k €92,7 k €
EBITDA107,6 k €93,4 k €76,2 k €-541,9 €-796,1 €45,3 k €52,4 k €
Operating result71,2 k €59,6 k €40,2 k €-541,9 €-796,1 €15 k €22,4 k €
Net result56,7 k €47,5 k €37,1 k €822,2 €-180,8 €11 k €14,4 k €
Balance sheet
Equity574 k €517,2 k €469,7 k €109,7 k €108,8 k €48,1 k €43,1 k €
Total assets745,5 k €670,8 k €637,3 k €109,8 k €109 k €228,9 k €242,2 k €
Cash13,2 k €8,4 k €22,5 k €2 k €42,2 k €15,9 k €
Debts171,6 k €153,5 k €167,6 k €112 €111 €180,8 k €199,2 k €
Other
Workforce1,8 ETP2,6 ETP2,1 ETP0,3 ETP0,9 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 9 ended

Active mandates

ALEXO

Chairman of the board of directors · since 01 septembre 2022 · 0870.896.286

Represented by Olivier Delaere

Active
SODIAP

Managing director · since 01 octobre 2020 · 0405.366.364

Represented by Tom Goderis

Active

Ended mandates

ARISTO

Chairman of the board of directors · since 30 décembre 2020 · until 31 août 2022 · 0434.718.564

Represented by Frank Coene

Ended
ARISTO

Director · since 30 décembre 2020 · 0434.718.564

Represented by Frank COENE

Ended
ARISTO

Chairman of the board of directors · since 22 décembre 2020 · 0434.718.564

Represented by Frank Coene

Ended
SODIAP

Managing director · since 22 décembre 2020 · 0405.366.364

Represented by Tom Goderis

Ended
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/07/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months6 months
Filing date12/05/202617/06/202513/06/202409/06/202307/06/202217/06/2021
General meeting03/04/202604/04/202505/04/202407/04/202301/04/202202/04/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

21 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202503/04/202612/05/2026DutchPDF
Abridged model31/12/202404/04/202517/06/2025DutchPDF
Abridged model31/12/202305/04/202413/06/2024DutchPDF
Abridged model31/12/202207/04/202309/06/2023DutchPDF
Abridged model31/12/202101/04/202207/06/2022DutchPDF
Abridged model31/12/202002/04/202117/06/2021DutchPDF
Micro model30/06/202028/09/202027/10/2020DutchPDF
Micro model30/06/201931/12/201928/01/2020DutchPDF
Micro model30/06/201831/12/201823/01/2019DutchPDF
Abridged model30/06/201730/12/201729/01/2018DutchPDF
Abridged model30/06/201630/12/201630/01/2017DutchPDF
Abridged model30/06/201512/12/201511/01/2016DutchPDF
Abridged model30/06/201429/12/201414/01/2015DutchPDF
Abridged model30/06/201305/01/201429/01/2014DutchPDF
Abridged model30/06/201205/01/201330/01/2013DutchPDF
Abridged model30/06/201130/12/201130/01/2012DutchPDF
Abridged model30/06/201011/12/201007/01/2011DutchPDF
Abridged model30/06/200912/12/200913/01/2010DutchPDF
Abridged model30/06/200807/01/200922/01/2009DutchPDF
Abridged model30/06/200705/01/200814/01/2008DutchPDF
Abridged model30/06/200606/01/200731/01/2007DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 9 ended

Active mandates

ALEXO

Chairman of the board of directors · since 01 septembre 2022 · 0870.896.286

Represented by Olivier Delaere

Active
SODIAP

Managing director · since 01 octobre 2020 · 0405.366.364

Represented by Tom Goderis

Active

Ended mandates

ARISTO

Chairman of the board of directors · since 30 décembre 2020 · until 31 août 2022 · 0434.718.564

Represented by Frank Coene

Ended
ARISTO

Director · since 30 décembre 2020 · 0434.718.564

Represented by Frank COENE

Ended
ARISTO

Chairman of the board of directors · since 22 décembre 2020 · 0434.718.564

Represented by Frank Coene

Ended
SODIAP

Managing director · since 22 décembre 2020 · 0405.366.364

Represented by Tom Goderis

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates17/07/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office10/08/2023
    MAATSCHAPPELIJKE ZETEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Restructuring11/05/2023
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates09/12/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates03/05/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates25/11/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates05/10/2020
    WIJZIGING RECHTSVORM - BENAMING - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Capital / shares16/03/2007
    KAPITAAL - AANDELEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202556,7 k €
  2. 2024
    Annual accounts 202447,5 k €
  3. 2024
    Name change057 - NB Pharma
  4. 2023
    Annual accounts 202337,1 k €
  5. 2022
    Annual accounts 2022822,2 €
  6. 2021
    Annual accounts 2021-180,8 €
  7. 2021
    Name changeNB Pharma
  8. 2008
    Annual accounts 200811 k €
  9. 2007
    Annual accounts 200714,4 k €
  10. 20/04/1999
    IncorporationPrivate limited company